2018 annual financial data
Xeris Biopharma Holdings 2018 Operating margin
Xeris Biopharma Holdings 2018 operating margin with verified reported values.
Direct answer
Operating margin was -2,407.46%.
Operating income was -59,344,000 USD and net income was -60,080,000 USD.
Operating cash flow was -56,279,000 USD.
Get free Xeris Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,465,000 USD
- Operating income
- -59,344,000 USD
- Net income
- -60,080,000 USD
- Operating cash flow
- -56,279,000 USD